Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Eidus

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
International Journal of Clinical Pharmacology, Therapy and Toxicology|January 1, 1974
Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugsL Eidus, A G Jessamine, D M Helbaque, et al.
Revue Canadienne De Biologie|June 1, 1974
Distribution of isoniazid inactivators determined in Eskimos and Canadian college students by a urine testL Eidus, M M Hodgkin, O Schaefer, et al.
International Journal of Clinical Pharmacology, Therapy and Toxicology|July 1, 1973
Evaluation of a new method for phenotyping of slow and rapid acetylatorsM M Hodgkin, A H Hsu, P Varughese, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 1, 1978
A national study to determine the prevalence of drug resistance in newly discovered previously untreated tuberculosis patients as well as in retreatment casesL Eidus, A G Jessamine, E S Hershfield, et al.
Research Communications in Chemical Pathology and Pharmacology|February 1, 1979
Phenotyping of South African black tuberculosis patients for inactivation of isoniazidL Eidus, E Glatthaar, M M Hodgkin, et al.
Bulletin of the World Health Organization|January 1, 1973
Simplification of isoniazid phenotyping procedure to promote its application in the chemotherapy of tuberculosisL Eidus, P Varughese, M M Hodgkin, et al.
The American Journal of Medicine|February 1, 1990
Thrombotic thrombocytopenic purpura following hemorrhagic colitis due to Escherichia coli O157:H7M J Kovacs, J Roddy, S Grégoire, et al.
American Journal of Nephrology|January 1, 1990
Successful treatment of renal allograft rejection in the presence of cytomegalovirus disease. A report of two casesK D Burns, L Johnson-Whittaker, R A Couture, et al.
International Journal of Clinical Pharmacology and Biopharmacy|July 1, 1979
Comparison of isoniazid phenotyping of black and white patients with emphasis on South African blacksL Eidus, E Glatthaar, M M Hodgkin, et al.
Journal of Clinical Gastroenterology|September 1, 1981
Risk factors for isoniazid (NIH)-induced liver dysfunctionD S Dickinson, W C Bailey, B I Hirschowitz, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
International Journal of Clinical Pharmacology, Therapy and Toxicology|January 1, 1974
Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugsL Eidus, A G Jessamine, D M Helbaque, et al.
Revue Canadienne De Biologie|June 1, 1974
Distribution of isoniazid inactivators determined in Eskimos and Canadian college students by a urine testL Eidus, M M Hodgkin, O Schaefer, et al.
International Journal of Clinical Pharmacology, Therapy and Toxicology|July 1, 1973
Evaluation of a new method for phenotyping of slow and rapid acetylatorsM M Hodgkin, A H Hsu, P Varughese, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 1, 1978
A national study to determine the prevalence of drug resistance in newly discovered previously untreated tuberculosis patients as well as in retreatment casesL Eidus, A G Jessamine, E S Hershfield, et al.
Research Communications in Chemical Pathology and Pharmacology|February 1, 1979
Phenotyping of South African black tuberculosis patients for inactivation of isoniazidL Eidus, E Glatthaar, M M Hodgkin, et al.
Bulletin of the World Health Organization|January 1, 1973
Simplification of isoniazid phenotyping procedure to promote its application in the chemotherapy of tuberculosisL Eidus, P Varughese, M M Hodgkin, et al.
The American Journal of Medicine|February 1, 1990
Thrombotic thrombocytopenic purpura following hemorrhagic colitis due to Escherichia coli O157:H7M J Kovacs, J Roddy, S Grégoire, et al.
American Journal of Nephrology|January 1, 1990
Successful treatment of renal allograft rejection in the presence of cytomegalovirus disease. A report of two casesK D Burns, L Johnson-Whittaker, R A Couture, et al.
International Journal of Clinical Pharmacology and Biopharmacy|July 1, 1979
Comparison of isoniazid phenotyping of black and white patients with emphasis on South African blacksL Eidus, E Glatthaar, M M Hodgkin, et al.
Journal of Clinical Gastroenterology|September 1, 1981
Risk factors for isoniazid (NIH)-induced liver dysfunctionD S Dickinson, W C Bailey, B I Hirschowitz, et al.
Pageof 7